Pay in 4 interest-free payments of $5.42 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
The trial enrolled 281 participants across 42 research and healthcare centers in the United States, randomized to once-weekly subcutaneous retatrutide (0.5, 4, 8, or 12 mg), once-weekly subcutaneous dulaglutide 1.5 mg (active comparator), or placebo, over a 36-week treatment period
Seven slightly overweight women and 5 men followed a diet with or without 3 g carnitine daily for 10 days
Every compound that produces meaningful physiological effects will produce some reactions in some people
Woodruff JD, Pickar JH
US$ 23.82
US$ 25.95
US$ 26.47
US$ 22.27
US$ 24.49
![Contract from Below [International Collectors' Edition] Zendikar](https://cdn.shopify.com/s/files/1/0304/5520/1930/products/285105c5-e3d2-59f0-bfc8-3ecf27e16154.jpg?v=1699035521)